Posters

EYE-LIGHT® technology for the treatment of Chalazion and Blepharitis

Poster Details

First Author: A.Rodriguez SPAIN

Co Author(s):    M. Amesty   L. Primavera   J. Alió              

Abstract Details

Purpose:

To evaluate the use of EYE-LIGHT®, OPE® TECHNOLOGY combined with LIGHT MODULATION® or LIGHT MODULATION® alone, in the treatment of Chalazion and Blepharitis. OPE® TECHNOLOGY is a polychromatic light which uses thermal pulses and LIGHT MODULATION® is a unique technology of photobiomodulation that allows endogenous heating of the eyelids.

Setting:

VISSUM MIRANZA, Alicante, Spain.

Methods:

26 patients with relevant history and acute symptoms of chalazion or blepharitis were scheduled for OPE®- LIGHT MODULATION® treatment or LIGHT MODULATION® alone. The ocular surface disease index (OSDI) score, subjective symptom score using VAS scale, height of the meniscus lacrimal, NIBUT (Non-Invasive Break-Up Time), bulbar redness and meibography (Meibo-Scan) of the upper and lower eyelids, were assessed before each session of treatment and after 1 month of the last session. The use of artificial tears was also recorded.

Results:

13 patients with chalazion (46.5 ± 20.5 years) and 13 with blepharitis (58.9 ± 17.4 years) were scheduled. The OSDI score improved after the therapy from moderated (24) to normal (7) in chalazion patients, and from severe (34) to mild (17) in blepharitis patients. The subjective symptoms with the VAS scale (0-100) improved from 25 to 7 and from 30 to 7 respectively. 54% of the patients resolved the chalazion after 4 sessions, the rest of them after 1 to 3. 69% of the patients improved the blepharitis after 4 sessions, the rest after 5 or 6.

Conclusions:

OPE® TECHNOLOGY combined with LIGHT MODULATION® or LIGHT MODULATION® alone, significantly improved patients suffering from chalazion avoiding surgical intervention. Blepharitis patients improved their condition by reducing symptoms and the frequency of using artificial tears.

Financial Disclosure:

None